Medicover AB Income Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	2,378	2,092	1,746	1,510	1,377
Revenue Growth (YoY)	13.69%	19.78%	15.64%	9.64%	38.04%
Cost of Revenue	1,827	1,644	1,387	1,170	982.4
Gross Profit	550.7	448.3	359.4	340.1	395
Selling, General & Admin	393.3	375.1	297.5	271.4	232.4
Operating Expenses	393.3	375.1	297.5	271.4	232.4
Operating Income	157.4	73.2	61.9	68.7	162.6
Interest Expense	-64	-58.8	-51.4	-34.5	-20.1
Interest & Investment Income	4.3	4.8	4.4	2.7	1
Earnings From Equity Investments	0.1	-	0.1	0.2	1
Currency Exchange Gain (Loss)	0.7	3.4	1.1	-3.3	1.8
Other Non Operating Income (Expenses)	1.6	0.4	0.2	2.4	0.3
EBT Excluding Unusual Items	100.1	23	16.3	36.2	146.6
Merger & Restructuring Charges	-1.7	-2.9	-0.7	-7.2	-3.2
Gain (Loss) on Sale of Investments	-	-	-	-3.2	0.4
Gain (Loss) on Sale of Assets	-	-	7.8	-	-
Asset Writedown	-	-	0.2	-6.3	-
Pretax Income	98.4	20.1	23.6	19.5	143.8
Income Tax Expense	25.7	5.5	5.2	5.8	37.2
Earnings From Continuing Operations	72.7	14.6	18.4	13.7	106.6
Minority Interest in Earnings	4.8	2.1	-0.8	-1.9	-4.8
Net Income	77.5	16.7	17.6	11.8	101.8
Net Income to Common	77.5	16.7	17.6	11.8	101.8
Net Income Growth	364.07%	-5.11%	49.15%	-88.41%	294.57%
Shares Outstanding (Basic)	151	150	149	149	148
Shares Outstanding (Diluted)	151	150	150	149	148
Shares Change (YoY)	0.52%	0.36%	0.47%	0.41%	4.66%
EPS (Basic)	0.51	0.11	0.12	0.08	0.69
EPS (Diluted)	0.51	0.11	0.12	0.08	0.69
EPS Growth	360.59%	-5.48%	49.16%	-88.48%	276.93%
Free Cash Flow	185.6	139.6	94.5	29.6	114.5
Free Cash Flow Per Share	1.23	0.93	0.63	0.20	0.77
Dividend Per Share	0.200	0.150	0.120	0.120	0.120
Dividend Growth	33.33%	25.00%	-	-	71.43%
Gross Margin	23.16%	21.43%	20.58%	22.52%	28.68%
Operating Margin	6.62%	3.50%	3.54%	4.55%	11.80%
Profit Margin	3.26%	0.80%	1.01%	0.78%	7.39%
Free Cash Flow Margin	7.80%	6.67%	5.41%	1.96%	8.31%
EBITDA	276.7	171.2	156.3	152.7	220.6
EBITDA Margin	11.63%	8.18%	8.95%	10.11%	16.02%
D&A For EBITDA	119.3	98	94.4	84	58
EBIT	157.4	73.2	61.9	68.7	162.6
EBIT Margin	6.62%	3.50%	3.54%	4.55%	11.80%
Effective Tax Rate	26.12%	27.36%	22.03%	29.74%	25.87%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.